OBJECTIVE: Optimizing flow and diminishing power loss in the Fontan circuit can improve hemodynamic efficiency, potentially improving the long-term outcomes. Computerized modeling has predicted improved energetics with a Y-graft Fontan. METHODS: From August to December 2010, 6 consecutive children underwent completion Fontan (n=3) or Fontan revision (n=3) using a bifurcated polytetrafluoroethylene Y-graft (18×9×9 mm in 2, 20×10×10 mm in 4) connecting the inferior vena cava to the right and left pulmonary arteries with separate graft limbs. The patents underwent magnetic resonance imaging (n=5) or computed tomography (n=1). Computational fluid dynamics assessed Fontan hemodynamics, power loss, and inferior vena cava flow splits to the branch pulmonary arteries. The clinical parameters were compared with those from 12 patients immediately preceding the present series who had undergone a lateral Fontan procedure. RESULTS: Despite longer crossclamp and bypass times (not statistically significant), the Y-graft Fontan patients had postoperative courses similar to those of the conventional Fontan patients. Other than 2 early readmissions for pleural effusions managed with diuretics, at 6 to 12 months of follow-up (mean, 8 months), all 6 patients had done well. Postoperative flow modeling demonstrated a balanced distribution of inferior vena cava flow to both pulmonary arteries with minimal flow disturbance. Improvements in hemodynamics and efficiency were noted when the Y-graft branches were anastomosed distally and aligned tangentially with the branch pulmonary arteries. CONCLUSIONS: The present preliminary surgical experience has demonstrated the clinical feasibility of the bifurcated Y-graft Fontan. Computational fluid dynamics showed acceptable hemodynamics with low calculated power losses and a balanced distribution of inferior vena cava flow to the pulmonary arteries as long as the branch grafts were anastomosed distally.
OBJECTIVE: Optimizing flow and diminishing power loss in the Fontan circuit can improve hemodynamic efficiency, potentially improving the long-term outcomes. Computerized modeling has predicted improved energetics with a Y-graft Fontan. METHODS: From August to December 2010, 6 consecutive children underwent completion Fontan (n=3) or Fontan revision (n=3) using a bifurcated polytetrafluoroethylene Y-graft (18×9×9 mm in 2, 20×10×10 mm in 4) connecting the inferior vena cava to the right and left pulmonary arteries with separate graft limbs. The patents underwent magnetic resonance imaging (n=5) or computed tomography (n=1). Computational fluid dynamics assessed Fontan hemodynamics, power loss, and inferior vena cava flow splits to the branch pulmonary arteries. The clinical parameters were compared with those from 12 patients immediately preceding the present series who had undergone a lateral Fontan procedure. RESULTS: Despite longer crossclamp and bypass times (not statistically significant), the Y-graft Fontan patients had postoperative courses similar to those of the conventional Fontan patients. Other than 2 early readmissions for pleural effusions managed with diuretics, at 6 to 12 months of follow-up (mean, 8 months), all 6 patients had done well. Postoperative flow modeling demonstrated a balanced distribution of inferior vena cava flow to both pulmonary arteries with minimal flow disturbance. Improvements in hemodynamics and efficiency were noted when the Y-graft branches were anastomosed distally and aligned tangentially with the branch pulmonary arteries. CONCLUSIONS: The present preliminary surgical experience has demonstrated the clinical feasibility of the bifurcated Y-graft Fontan. Computational fluid dynamics showed acceptable hemodynamics with low calculated power losses and a balanced distribution of inferior vena cava flow to the pulmonary arteries as long as the branch grafts were anastomosed distally.
Authors: Dennis D Soerensen; Kerem Pekkan; Diane de Zélicourt; Shiva Sharma; Kirk Kanter; Mark Fogel; Ajit P Yoganathan Journal: Ann Thorac Surg Date: 2007-06 Impact factor: 4.330
Authors: Alison L Marsden; Adam J Bernstein; V Mohan Reddy; Shawn C Shadden; Ryan L Spilker; Frandics P Chan; Charles A Taylor; Jeffrey A Feinstein Journal: J Thorac Cardiovasc Surg Date: 2009-02 Impact factor: 5.209
Authors: Christof Stamm; Ingeborg Friehs; Lennart F Duebener; David Zurakowski; John E Mayer; Richard A Jonas; Pedro J del Nido Journal: Ann Thorac Surg Date: 2002-12 Impact factor: 4.330
Authors: Kartik S Sundareswaran; Kerem Pekkan; Lakshmi P Dasi; Kevin Whitehead; Shiva Sharma; Kirk R Kanter; Mark A Fogel; Ajit P Yoganathan Journal: Am J Physiol Heart Circ Physiol Date: 2008-10-17 Impact factor: 4.733
Authors: Lakshmi P Dasi; Resmi Krishnankuttyrema; Hiroumi D Kitajima; Kerem Pekkan; Kartik S Sundareswaran; Mark Fogel; Shiva Sharma; Kevin Whitehead; Kirk Kanter; Ajit P Yoganathan Journal: J Thorac Cardiovasc Surg Date: 2009-03 Impact factor: 5.209
Authors: Kevin K Whitehead; Kerem Pekkan; Hiroumi D Kitajima; Stephen M Paridon; Ajit P Yoganathan; Mark A Fogel Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Christopher M Haggerty; Diane A de Zélicourt; Maria Restrepo; Jarek Rossignac; Thomas L Spray; Kirk R Kanter; Mark A Fogel; Ajit P Yoganathan Journal: Ann Biomed Eng Date: 2012-07-10 Impact factor: 3.934
Authors: Guruprasad A Giridharan; Mickey Ising; Michael A Sobieski; Steven C Koenig; Jun Chen; Steven Frankel; Mark D Rodefeld Journal: ASAIO J Date: 2014 Nov-Dec Impact factor: 2.872
Authors: Kalpi Desai; Christopher M Haggerty; Kirk R Kanter; Jarek Rossignac; Thomas L Spray; Mark A Fogel; Ajit P Yoganathan Journal: Interact Cardiovasc Thorac Surg Date: 2013-04-05
Authors: Christopher M Haggerty; Kevin K Whitehead; James Bethel; Mark A Fogel; Ajit P Yoganathan Journal: Ann Thorac Surg Date: 2015-01-22 Impact factor: 4.330